chrisvoncsefalvay/vaers-outcomes huggingface dataset:
has not had her menstrual cycle since getting the vaccine. She was due before her initial vaccine meanig she would have been late, however it never came on and it has been 2 months now.
Overview of the five days after pt's measle injection: Pt slept approximately 18-22 hours a day. She nursed and threw-up most times after nursing. Pt did not eat or drink water except for a few drops here and there. Pt had a high fever for five days. Pt was in pain, unsteady, cried easily, and weak. 10/26/02 11am pt received the measles vaccine. 10pm pt threw up entire belly after nursing. 10/27/02 fever all day. 6am woke up with high fever 102D. 8:30-9:30am slept-9:45am nursed and threw-up. 10-11am slept. 3pm-6pm slept. 7-10pm woke up screaming. 10:30pm nursed and did not throw up. 11pm-9:30am slept with occasional wake ups. 10/28/02 fever all ay. 9:30am woke up pt cried and slept all day with occasional wake ups to nurse and throw up. I spoke with MD who said that a dose of Tylenol which would give her "false" thoughts of feeling better in order to drink and eat without throwing up. After the Tylenol wore off pt was worse than before with more crying and listlessness. 4-5pm nursed pt to a full belly which she threw up at 6pm. 6:30-put pt to bed. 10/29/02 6am nursed and little water. 6:30-11am slept. 11am nursed. 11:15 slept. Noon up read books. 1pm nursed. 1:10 nap. 3pm nursed. 4pm not eating fever is down. 6pm nursed and slept. 8:30 threw up green. 10/30/02 seems better but very weak from vaccine. 10/31/02 pt is in pain, unsteady, cries easily, weak and sleeps a lot.
ACHES ALL OVER/PAIN; COULD NOT SLEEP; COULD NOT WALK; BEDRIDDEN THE WHOLE NEXT DAY; CHILLS PULSING THROUGHOUT BODY; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced aches all over/pain, could not sleep, could not walk, bedridden the whole next day, and chills pulsing throughout body. The action taken with covid-19 vaccine was not applicable. The patient was recovering from chills pulsing throughout body, aches all over/pain, could not sleep, could not walk, and bedridden the whole next day. This report was non-serious.
pt recvd vax & devel headache, became quiet & disoriented; episode of incontinence, & began exhibiting unusual behavior; pt taken to hosp & dx w/ encephalopathy; pt was unresponsive & sufferred a cardiac arrest;
Varicella Vaccine and TB skin test administered at well child visit. Child cried, hyperventilated, apparently held breath. Became unresponsive, eyes rolled back, brief (<30sec) generalized tonic-clonic seizure. Appears briefly confused, tightened tired post- ictally. Fully recovering before leaving office.
Patient received dose 1 of the COVID Moderna vaccine (lot 041B21A, exp 5/6/2021) at 1430. At 1500, EMT approached patient who was crying and sweaty. Patient complained of anxiety, itching, chest tightness, feeling sweaty, and shortness of breath. Vital signs: O2 99%, pulse 106, blood pressure 140/90, respirations 20. Allergies to bee stings. Medical condition includes severe anxiety disorder. Medications: Lexapro, Ativan as needed. PHN approached to help assess the patient. Patient reported having the same reaction as when she has previously had anxiety and panic attacks. At 1507, vital signs: O2 99%, pulse 87, blood pressure 128/80, respirations 18. Patient reported symptoms had mostly resolved except for lingering itching. PHN offered Benadryl but patient declined. At 1516, patient reported all symptoms had resolved. Vital signs: O2 99%, pulse 74, blood pressure 118/78, respirations 18. Patient stood up with PHN and EMT nearby, reported no symptoms. Patient left walking with steady gait at 1520.
1st dose 21Dec2019, 2nd 30Jul2022; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingrix) (batch number FA95N, expiry date 28th July 2023) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 21st December 2019).   On 30th July 2022, the patient received the 2nd dose of Shingrix. On 30th July 2022, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK Receipt Date: 28-OCT-2022 Reporter's comment: Pharmacist reported that a patient got first dose of Shingrix on 21st December 2019 and 2nd dose on 30th July 2022. The vaccine administration facility was the same as primary reporter. No information of the patient provided. The reporter consented to follow-up. Additional Supportive Information: The patient received 2nd dose of Shingrix later than the recommended interval, which led to lengthening of vaccination schedule.
102.1 fever for 24 hours that couldn't be lowered with Tylenol and Motrin, chills, body aches, headache. 99.7 fever at 48 hours dizzy and tired for 5 days so far, this lasted 10 days with the first shot
Suspected vaccination failure; shingles; very painful; had three shingles shots; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis and Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine, the 2nd dose of Shingles vaccine and the 3rd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, pain and extra dose administered. On an unknown date, the outcome of the vaccination failure, shingles, pain and extra dose administered were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine, Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: Age at vaccination was not reported. The age group was selected as adult as per vaccine indication. The patient had three shingles shots, which led to  extra dose administered. The patient still experienced shingles. It was reported as shingles shot was very painful every time. This case was reported as suspected vaccination failure since the details regarding time to onset and laboratory confirmation were not reported.
Made my arm sore many days; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.  Additional details were provided as follows:  The age at vaccination was not reported.  The age group was not reported but was captured as adult as per vaccine indication.  After receiving 1st dose of Shingrix, the patient experienced arm sore for many days. The patient said that it was better than shingles. The patient was going to take 2nd dose of Shingles vaccine in few weeks.
Pt vaccinated with DTP/OPV became irritable, body temp 100.f. No vomiting or other symptoms; Fell asleep at 6AM when parents went to wake him for feeding noted to be unresponsive.  Paramedics were called brought to ER.
c/o lips numb. Observation 60 minutes after the reaction and gave OJ. Patient stated it was resolving and departed on her own.
Energy level low; Achy feeling; sick feeling; Chills; headache; nausea comes and goes; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Energy level low), PAIN (Achy feeling), MALAISE (sick feeling), CHILLS (Chills) and HEADACHE (headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced ASTHENIA (Energy level low), MALAISE (sick feeling), CHILLS (Chills), HEADACHE (headache) and NAUSEA (nausea comes and goes). 12-Mar-2021, the patient experienced PAIN (Achy feeling). At the time of the report, ASTHENIA (Energy level low), PAIN (Achy feeling), MALAISE (sick feeling), CHILLS (Chills), HEADACHE (headache) and NAUSEA (nausea comes and goes) outcome was unknown.            Concomitant medications were not provided.  Treatment information was not provided. The action taken with  mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) was not applicable.
Had me under the weather; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of unwell in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced unwell (Verbatim: Had me under the weather). The outcome of the unwell was recovered/resolved (duration 24 hrs).   It was unknown if the reporter considered the unwell to be related to Shingles vaccine.     It was unknown if the company considered the unwell to be related to Shingles vaccine.   Additional Information: GSK receipt date: 03-MAR-2023 This case was reported by a patient via interactive digital media. The patient stated Shingles vaccine had him /her under the weather for 24 hours approximately. Follow-up would not possible as no contact details were available.
63 year old patient had 3 vaccines administered, Fluzone Quad, Prevnar-20 and Pfizer Bivalent.  About 2 hours later patient started with aches and  fever.   About 12 hours later patient started Vomiting.  Patients daughter is bringing her to provider, or emergency Dept
Very mild side effects from the vaccine; Body ache; This spontaneous case was reported by an other health care professional and describes the occurrence of IMMUNISATION REACTION (Very mild side effects from the vaccine) and PAIN (Body ache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) for an unknown indication.    Concomitant products included LEVOTHYROXINE for an unknown indication.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) at an unspecified dose. On an unknown date, the patient experienced IMMUNISATION REACTION (Very mild side effects from the vaccine) and PAIN (Body ache). At the time of the report, IMMUNISATION REACTION (Very mild side effects from the vaccine) outcome was unknown and PAIN (Body ache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  Treatment medication information was not provided by the reporter.  Patient was prescribed Paxlovid that she started two days ago and having some horrible side effects from it including pelvic and stomach pain and then she guess, GERD and as well as horrible the worst taste in her mouth that she ever had in her life that will not go away. She have taken today's dose and she don't want to take this medication any more and she guess they can be feel worse than the COVID (Further clarification unknown) she was looking for guidance on that.  This case was identified as part of a retrospective clean-up activity where certain emails received in the moderna mailbox were missed to be booked-in.
My son was given his dtap and polio vaccines 9 days before he turned 4. So now he might have to have them again.
pt was exposed & broke out in the rash (red raised bumps) & devel a fever;
Initial report was received 22 May 2008 from a health care provider.  A 61-year-old male patient with no past medical history, had received a pre-exposure right deltoid intramuscular injection of IMOVAX RABIES vaccine (lot number not reported) on 23 April 2008 and three days later, he developed a temperature of 103 Fahrenheit and night sweats.  The patient was prescribed a five day regimen of ZITHROMAX.  The patient had moved to another state to live with his son and developed a backache (onset date not provided).  He was evaluated by an orthopedic physician and had an MRI performed which indicated a positive abscess located at L4-L5 and was hospitalized.  Cultures were pending at the time of the report.  The reporter stated the patient had surgery on 21 May 2008 or 22 May 2008.  The patient had received two prior doses of IMOVAX RABIES vaccine on 02 April 2008 and 09 April 2008 as the first two doses of the pre-exposure series for foreign travel.  At the time of the report, the patient had not recovered from the event.
Patient hospitalized with preterm ROM. "She subsequently went into labor and had a precipitous delivery. She had an uncomplicated SVD of a viable male infant weighing 4 # 4 oz. Her postpartum course was uncomplicated." Of note, patient was covid positive on 1/4/22.
Around 6:15 PM the day of the vaccine, began to experience chills and a headache. I also became very dehydrated quickly and started to rest. I woke up around 8:30PM the same day with a fever of 102.7F, but no longer had chills. The headache had gotten worse and I took Ibuprofen to help the fever and headache. I feel back asleep until 11:30PM the same day when I was feeling better and had come down from my fever. I slept the rest of the night and woke up feeling dehydrated still and tired. When looking at my Apple Watch, my heart rate jumped to 90-120 BPM when the symptoms started and stayed around there until when I woke up the next day. The symptoms ran their course and I did not have any other events until April 13th, 3 days after the vaccine when I developed a dry cough.
This spontaneous report as received from a physician refers to a 19 year old female, non pregnant patient with no medical history and no drug reactions or allergies. On 24-SEP-2013 the patient was vaccinated with a third dose of GARDASIL (lot number, dose, route and site of administration were not reported). The dates of administration of the first two doses of GARDASIL were unspecified. No concomitant medications were reported. The patient presented to the hospital on 29-SEP-2013 with increased liver function tests, increased creatinine kinase levels and rhabdomyolysis. The physician reported that the patient had been given extra fluids to treat rhabdomyolysis, and the patient's liver function tests were worsening. The patient was very weak and couldn't move around a lot. The outcome of adverse events was reported as not recovered. The relatedness between vaccination with GARDASIL and adverse events was not reported. Upon internal review rhabdomyolysis was considered to be medically significant. Additional information has been requested.
Localized discomfort and stiffness at site, redness and warmth and slight swelling below injection area (Deltoid) to elbow X4 days, reported by phone to clinic staff on 6/14/18 at 10:00 P.M. He was instructed by Dr. to take BENADRYL 25MG PO and apply ice pack to site for 10-15 minutes. Patient reported redness is improving and has no discomfort 6/15/18 at 9:45 A.M.
Information has been received from a physician referring to multiple unspecified patients of unknown age and gender. On unknown dates, the patients were vaccinated with RECOMBIVAX HB (lot # L029631, expiration date: 14-AUG-2017, route and dose were unknown) that were improperly stored. No adverse effects were reported. There was no previous temperature excursion. This is one of several reports received from the same reporter. Additional information has been requested.
Patient received Moderna BIV 6m-5yrs instead of Moderna BIV 6+. Patient will be revaccinated with appropriate dosage.
I developed hives after my Pfizer shots that progressed into chronic urticaria. It improved with antihistamine and recurred after my booster. However this time even worse.
Seizures starting 3 months after vaccination (early May), 1 last 3 minutes, 1 shorter. Double shoulder dislocation when admitted to ER. Given lamicdol for seizures.
Second shot rescheduled for March 13th, and there will be a difference of more than 36 days; This spontaneous case was reported by a consumer and describes the occurrence of OFF LABEL USE (Second shot rescheduled for March 13th, and there will be a difference of more than 36 days) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced OFF LABEL USE (Second shot rescheduled for March 13th, and there will be a difference of more than 36 days). At the time of the report, OFF LABEL USE (Second shot rescheduled for March 13th, and there will be a difference of more than 36 days) outcome was unknown.         No treatment information was reported.   Reporter did not allow further contact
Clients son contacted this RN and reported that "on 2/14/14 his mother developed blister like rash on her face and belly. No fever, no malaise, no acute discomfort." No itchiness was reported.
joints were sore; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (joints were sore) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (joints were sore). At the time of the report, ARTHRALGIA (joints were sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were mentioned. No treatment details were reported.
Elevated A1C levels, elevated blood glucose levels. Possible Diabetes type 1 diagnosis.
indication=Treatment of COVID-19; indication=Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 36-year-old male patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Lot number: FJ1620) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Sulfa" (unspecified if ongoing). Concomitant medication(s) included: SIMVASTATIN. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", COVID-19 (medically significant), outcome "not recovered" and all described as "indication=Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (04May2022) Negative; (07May2022) positive. Therapeutic measures were taken as a result of covid-19. Clinical course: Other medication details: other medication in 2weeks product=Simvastatin. Adverse event: Tested negative after Paxlovid course. 3 days later, tested positive. The next day (4th day post course completion) I was more positive (darker antigen band and relative to control band) and exhibiting some symptoms including nasal pressure and some muscle aches. Adverse event start date: 02May2022 If patient recovered: Not recovered If treatment ae: No Known allergies: Sulfa.  No follow-up attempts possible. No further information expected.; Sender's Comments: Based on the information available  a possible contributory role of the suspect  cannot be excluded for the reported events of covid-19 and drug ineffective.
Information has been received from a registered pharmacist concerning an 84 year old female patient who on 01-JUN-2009 was vaccinated with a dose of PNEUMOVAX 23. On an unspecified date, after getting the PNEUMOVAX 23, the patient experienced swollen arm. It was reported that on unknown timeframe "in the past", the patient had received a dose of PNEUMOVAX 23. The patient sought unspecified medical attention. The patient's final outcome was not reported. No further information is available.
Awoke from sleep with very painful aching in both legs and charlie-horse-like cramping in both feet.  I was unable to get out of bed to walk because of the pain.  My pain level was 8 out of 10, and this pain was worse than any flu-like aching I have ever previously experienced.  Symptoms also included profuse sweating, chills, and hot flashes.  The symptoms kept me awake for most of the night.  The symptoms began improving the next day and I felt general malaise and bilateral lower extremity aching at that time.  These symptoms resolved the morning of 10/21/2010.  I did not seek formal medical attention.
EYES ROLLING; SHAKY; DIZZY; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 09-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 10-MAR-2021, the subject experienced eyes rolling. On 10-MAR-2021, the subject experienced shaky. On 10-MAR-2021, the subject experienced dizzy. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from eyes rolling, shaky, and dizzy. This report was non-serious.
My arm at the injection site was red, hot and itchy.  It remained that way for 2 days.  The itching spread across my interior arm a bit.  After 2 days, I began to experience lightheadedness and that has continued.  I also started having a headache on April 11th around 2 pm and it is continuing.
Patient husband said had shoulder pain & needed to see MD for pain meds after shot given on 10/17/11.
I received the vaccine on 2/6/19. I started having severe abdominal pain on 2/10-11/19 where I was unable to eat but did not have nausea, vomiting, or diarrhea. Then my left arm started hurting on 2/20/19 and did not stop hurting. It started off as a deep aching that felt like someone had a 10 lb dumbbell on the upper part of my arm and then transitioned to L forearm pain and L hand numbness on 2/22/19. This then transitioned to L hand burning on 2/26/19 and went back to L arm aching/heaviness on 3/2/19 with some residual numbness and burning in the L hand at times. Currently L arm is still having aching pain/heaviness and feels tremulous at times and weaker than my R arm.